🔥🐔 BizChicken 🐔🔥

Companies Similar to ImmuCell Corporation

Sign Up Today!

Sign up for BizChicken and discover more about the corporations around you.

ImmunityBio, Inc.

ImmunityBio, Inc. logo
Market Cap: High
Employees: Medium

Therapies and Vaccines

Immunity Bio, Inc. is a clinical-stage biotechnology company developing therapies and vaccines to treat cancers and infectious diseases, with a focus on immunotherapy and cell therapy platforms. The company collaborates with several institutes and has multiple therapeutic agents in clinical trials.

Tags: biotechnology, cancer, cell therapy, immunotherapy, infectious diseases, vaccines

Symbol: IBRX

Recent Price: $2.68

Industry: Biotechnology

CEO: Mr. Richard Gerald Adcock

Sector: Healthcare

Employees: 622

Address: 3530 John Hopkins Court, San Diego, CA 92121

Phone: 858 633 0300

Last updated: 2024-12-31

Lyell Immunopharma, Inc.

Lyell Immunopharma, Inc. logo
Market Cap: Low
Employees: Low

LYL797, LYL845, NY-ESO-1

Lyell Immunopharma, Inc. is a biopharmaceutical company developing T cell therapies focused on treating patients with solid tumors using advanced genetic and epigenetic reprogramming technologies.

Tags: T cell therapy, biotechnology, cancer treatment, epigenetic reprogramming, genetic reprogramming, solid tumors

Symbol: LYEL

Recent Price: $0.62

Industry: Biotechnology

CEO: Dr. Lynn Seely M.D., Ph.D.

Sector: Healthcare

Employees: 224

Address: 201 Haskins Way, South San Francisco, CA 94080

Phone: 650 695 0677

Leadership

  • Lynn Seely, M.D., President & Chief Executive Officer
  • Stephen Hill, Chief Operating Officer
  • Matthew Lang, J.D., Chief Business Officer
  • Gary Lee, Ph.D., Chief Scientific Officer
  • Charles Newton, Chief Financial Officer
  • Ellen Rose, Senior Vice President, Investor Relations and Communications
  • Bryan Selby, Senior Vice President, Clinical Development Operations
  • Ann Tomlin, Senior Vice President, Human Resources
  • Rick Klausner, M.D., Founder & Board Chair
  • Crystal Mackall, M.D., Founder
  • Stan Riddell, M.D., Founder
  • Hans Bishop, Director
  • Otis Brawley, M.D., Director
  • Catherine Friedman, Director
  • Elizabeth Nabel, M.D., Director
  • Robert Nelsen, Director
  • William Rieflin, Director

Last updated: 2024-12-31

INmune Bio, Inc.

INmune Bio, Inc. logo
Market Cap: Low
Employees: Lowest

INKmune

INmune Bio, Inc. is a clinical-stage immunotherapy company focused on developing drugs to reprogram the patient's innate immune system for the treatment of hematologic malignancies, solid tumors, chronic inflammation, and Alzheimer's disease.

Tags: Alzheimer's disease, chronic inflammation, hematologic malignancies, immunotherapy, solid tumors

Symbol: INMB

Recent Price: $4.65

Industry: Biotechnology

CEO: Dr. Raymond Joseph Tesi M.D.

Sector: Healthcare

Employees: 11

Address: 225 NE Mizner Boulevard, Boca Raton, FL 33432

Phone: 858 964 3720

Last updated: 2024-12-31

ImmuCell Corporation

ImmuCell Corporation logo
Market Cap: Lowest
Employees: Low

First Defense

Immu Cell Corporation develops, manufactures, and markets products that enhance the health and productivity of dairy and beef cattle. Its offerings include First Defense, Tri-Shield First Defense, California Mastitis Test, and Dual-Force First Defense, with a focus on animal health and nutritional supplements.

Tags: Animal Health, Beef Cattle, Dairy Cattle, First Defense, Mastitis

Symbol: ICCC

Recent Price: $4.82

Industry: Biotechnology

CEO: Mr. Michael F. Brigham

Sector: Healthcare

Employees: 75

Address: 56 Evergreen Drive, Portland, ME 04103

Phone: 207 878 2770

Last updated: 2024-12-31

OmniAb, Inc.

OmniAb, Inc. logo
Market Cap: Medium
Employees: Low

Omni Ab platform

Omni Ab, Inc., a biotechnology company, provides therapeutic antibody discovery technologies in the United States. The company's platform leverages transgenic animals to generate human-like antibodies for therapeutic applications.

Tags: biotechnology, discovery platform, therapeutic antibodies, transgenic animals

Symbol: OABI

Recent Price: $3.56

Industry: Biotechnology

CEO: Mr. Matthew W. Foehr

Sector: Healthcare

Employees: 106

Address: 5980 Horton Street, EmeryVille, CA 94608

Phone: 510 250 7800

Leadership

  • Matt Foehr, Chief Executive Officer
  • Kurt Gustafson, Chief Financial Officer
  • Charles Berkman, JD, Chief Legal Officer and Secretary
  • Yasmina Abdiche, PhD, Vice President, Exploratory Research
  • Laurel Bernstein, PhD, Vice President, Intellectual Property
  • Neil Castle, PhD, Vice President, Biology
  • Bob Chen, PhD, Sr. Director, Discovery Systems
  • Ellen Collarini, PhD, Sr. Director, Cell Biology
  • Bill Harriman, PhD, Sr. Vice President, Antibody Discovery
  • Christel Iffland, PhD, Sr. Vice President, Antibody Technologies
  • Shelley Izquierdo, PhD, Sr. Director, Antibody Discovery
  • Doug Krafte, PhD, Site Head – Durham, North Carolina Sr. Vice President, Ion Channels/Transporters
  • Phil Leighton, PhD, Fellow
  • Cia McCaffrey, Vice President, People and Talent
  • Anil Nair, PhD, Vice President, In Silico Discovery
  • Todd Pettingill, CFA, Vice President, Business Development and Strategy
  • Chris Silvia, PhD, Vice President, Data Sciences and Corporate IT
  • Eric Vajda, PhD, Vice President, Preclinical R&D
  • Marie-Cecile van de Lavoir, DVM, PhD, Sr. Vice President, Technical Operations and Genetics
  • Donna Ventura, CPA, Sr. Vice President, Corporate Controller
  • Carolyn R. Bertozzi, PhD, Board Member
  • Sarah Boyce, President and Chief Executive Officer
  • Jennifer Cochran, PhD, Board Member
  • Matthew W. Foehr, President and Chief Executive Officer
  • John Higgins, Board Chair
  • Steve Love, Chief Financial Officer

Last updated: 2024-12-31

Sensei Biotherapeutics, Inc.

Sensei Biotherapeutics, Inc. logo
Market Cap: Lowest
Employees: Lowest

Immuno Phage platform

Sensei Biotherapeutics, Inc. is a biopharmaceutical company focused on the discovery and development of immunotherapies for cancer, leveraging platforms such as Immuno Phage and Tumor Microenvironment Activated Biologics.

Tags: bacteriophage, biopharmaceutical, cancer treatment, immunotherapy, monoclonal antibodies

Symbol: SNSE

Recent Price: $0.48

Industry: Biotechnology

CEO: Mr. John K. Celebi M.B.A.

Sector: Healthcare

Employees: 28

Address: 451 D Street, Rockville, MD 02210

Phone: 240 243 8000

Last updated: 2024-12-31

Celldex Therapeutics, Inc.

Celldex Therapeutics, Inc. logo
Market Cap: High
Employees: Low

therapeutic monoclonal and bispecific antibodies

Celldex Therapeutics is a biopharmaceutical company focused on developing therapeutic monoclonal and bispecific antibodies for treating inflammatory diseases and cancers.

Tags: biopharmaceutical, bispecific antibodies, cancer treatment, inflammatory diseases, monoclonal antibodies

Symbol: CLDX

Recent Price: $25.12

Industry: Biotechnology

CEO: Mr. Anthony S. Marucci M.B.A.

Sector: Healthcare

Employees: 160

Address: Perryville III Building, Hampton, NJ 08827

Phone: 908 200 7500

Leadership

  • Anthony S. Marucci, Founder, President, Chief Executive Officer and Director
  • Tibor Keler, Ph.D., Founder, Executive Vice President and Chief Scientific Officer
  • Diane C. Young, M.D., Senior Vice President and Chief Medical Officer
  • Elizabeth Crowley, Senior Vice President, Chief Product Development Officer
  • Sam Martin, Senior Vice President and Chief Financial Officer
  • Ronald A. Pepin, Ph.D., Senior Vice President and Chief Business Officer
  • Richard Wright, Ph.D., Senior Vice President and Chief Commercial Officer
  • Sarah Cavanaugh, Senior Vice President, Corporate Affairs and Administration
  • Margo Heath-Chiozzi, M.D., Senior Vice President, Regulatory Affairs
  • Freddy A. Jimenez, Esq., Senior Vice President and General Counsel
  • Karen L. Shoos, J.D., Former Chair, Director of Operations, Maryland Tech Council Venture Mentoring Services Program
  • Keith L. Brownlie, Former Partner, Ernst & Young LLP
  • Herbert J. Conrad, Former President, Roche Pharmaceuticals US
  • James J. Marino, J.D., Former Partner, Dechert LLP
  • Harry H. Penner, Jr., J.D., L.L.M., Former Chairman and CEO, Nascent Bioscience
  • Cheryl L. Cohen, President, CLC Consulting; Former Chief Commercial Officer of Medivation, Inc.
  • Dr. Garry Neil, Chief Executive Officer; Chair of the Board, Avalo Therapeutics
  • Rita Jain, M.D., Former Executive Vice President, Chief Medical Officer of ChemoCentryx, Inc.
  • Carl June, M.D.,
  • Michel Nussenzweig, M.D., Ph.D.,
  • Marc E. Rothenberg M.D., Ph.D.,
  • Joseph Schlessinger, Ph.D.,
  • Louis Weiner, M.D.,

Last updated: 2024-12-31

IGM Biosciences, Inc.

IGM Biosciences, Inc. logo
Market Cap: Medium
Employees: Low

IGM-2323

IGM Biosciences, Inc. is a biotechnology company focused on developing Immunoglobulin M (Ig M) antibodies for treating cancer, infectious diseases, and autoimmune and inflammatory diseases. Their lead product candidate, IGM-2323, is in Phase 2 clinical trials for B cell Non-Hodgkin's lymphoma.

Tags: antibodies, biotechnology, cancer, clinical trials, pharmaceutical

Symbol: IGMS

Recent Price: $6.05

Industry: Biotechnology

CEO: Ms. Mary Beth Harler M.D.

Sector: Healthcare

Employees: 204

Address: 325 East Middlefield Road, Mountain View, CA 94043

Phone: 650 965 7873

Last updated: 2024-12-31

Immunome, Inc.

Immunome, Inc. logo
Market Cap: Medium
Employees: Low

IMM-ONC-01, IMM-BCP-01

Immunome, Inc. is a biopharmaceutical company focused on developing antibody therapeutics for oncology and infectious diseases, offering innovative solutions such as IMM-ONC-01 for cancer and IMM-BCP-01 for COVID-19 treatment.

Tags: antibody therapeutics, biopharmaceutical, infectious disease, oncology

Symbol: IMNM

Recent Price: $10.28

Industry: Biotechnology

CEO: Dr. Clay B. Siegall Ph.D.

Sector: Healthcare

Employees: 78

Address: 665 Stockton Drive, Exton, PA 19341

Phone: 610 321 3700

Last updated: 2024-12-31

Imunon, Inc.

Imunon, Inc. logo
Market Cap: Lowest
Employees: Lowest

GEN-1, Thermo Dox

Imunon, Inc. is a clinical stage biotechnology company specializing in the development and commercialization of DNA-based immunotherapies, vaccines, and directed chemotherapies, focusing on products such as GEN-1 for ovarian cancer and Thermo Dox for various cancer indications.

Tags: Biotechnology, Cancer Treatment, DNA Therapies, Immunotherapy, Vaccines

Symbol: IMNN

Recent Price: $0.82

Industry: Biotechnology

CEO: Dr. Stacy R. Lindborg Ph.D.

Sector: Healthcare

Employees: 33

Address: 997 Lenox Drive, Lawrenceville, NJ 08648

Phone: 609 896 9100

Leadership

  • Stacy R. Lindborg, PhD, President, Chief Executive Officer, and Board Director
  • David Gaiero, Chief Financial Officer
  • Khursheed Anwer, PhD, MBA, Executive Vice President and Chief Science Officer
  • Kristin Longobardi, MBA, Senior Vice President, Strategic Operations
  • Susan Eylward, General Counsel and Corporate Secretary
  • Michael H. Tardugno,
  • Frederick J. Fritz,
  • Donald Braun, PhD,
  • Christine Pellizzari, JD,
  • James E. Dentzer,

Last updated: 2024-12-31

Immuneering Corporation

Immuneering Corporation logo
Market Cap: Lowest
Employees: Low

IMM-1-104 and IMM-6-415

Immuneering Corporation is a biopharmaceutical company focused on developing oncology and neuroscience product candidates, with key products like IMM-1-104 for cancer treatment and IMM-6-415 for solid tumors.

Tags: biopharmaceutical, cancer treatment, drug development, neuroscience, oncology

Symbol: IMRX

Recent Price: $2.25

Industry: Biotechnology

CEO: Dr. Benjamin J. Zeskind M.B.A., Ph.D.

Sector: Healthcare

Employees: 66

Address: 245 Main Street, Cambridge, MA 02142

Phone: 617 500 8080

Last updated: 2024-12-31

Immunic, Inc.

Immunic, Inc. logo
Market Cap: Low
Employees: Low

IMU-838

Immunic, Inc. develops a pipeline of selective oral immunology therapies for the treatment of chronic inflammatory and autoimmune diseases. Its lead development program is IMU-838, in Phase 2 clinical trials for multiple conditions, including relapsing-remitting multiple sclerosis.

Tags: autoimmune diseases, biopharmaceutical, chronic inflammatory diseases, clinical trials, immunology, therapies

Symbol: IMUX

Recent Price: $1.03

Industry: Biotechnology

CEO: Dr. Daniel Vitt Ph.D.

Sector: Healthcare

Employees: 85

Address: 1200 Avenue of the Americas, New York, NY 10036

Phone: 332 255 9818

Last updated: 2024-12-31

Neogen Corporation

Neogen Corporation logo
Market Cap: High
Employees: High

Accu Point Advanced

Neogen Corporation develops, manufactures, and markets products for food and animal safety through its Food Safety and Animal Safety segments, offering diagnostic test kits and sanitation tests for foodborne pathogens and other contaminants.

Tags: Animal Safety, Diagnostics, Food Safety, Foodborne Pathogens, Sanitation

Symbol: NEOG

Recent Price: $12.33

Industry: Medical - Diagnostics & Research

CEO: Mr. John Edward Adent

Sector: Healthcare

Employees: 2917

Address: 620 Lesher Place, Lansing, MI 48912

Phone: 517 372 9200

Last updated: 2024-12-31

NexImmune, Inc.

NexImmune, Inc. logo
Market Cap: Lowest
Employees: Lowest

Artificial Immune Modulation

Nex Immune, Inc., a clinical-stage biotechnology company, develops therapies for cancer and immune-mediated diseases using its Artificial Immune Modulation platform. The company is advancing cell therapy candidates including NEXI-001, NEXI-002, and NEXI-003.

Tags: T cell immunotherapies, biotechnology, cancer, cell therapy, immune-mediated diseases, nanoparticle technology

Symbol: NEXI

Recent Price: $0.15

Industry: Biotechnology

CEO: Mr. John Trainer M.B.A.

Sector: Healthcare

Employees: 6

Address: 9119 Gaither Road, Gaithersburg, MD 20877

Phone: 301 825 9810

Leadership

  • Kristi Jones, Chief Executive Officer
  • Mathias Oelke, Ph.D., Chief Scientific Officer
  • Daniel Bednarik Ph.D., Senior Vice President, Molecular Engineering & Protein Design
  • Jack Ragheb, Senior Vice President, Translational Science
  • Tonya Catterton, Vice President, Quality & Compliance
  • Tim Stover, Vice President, Corporate Controller
  • Karen Haslbeck, Head, Human Resources
  • Matt Schiller, Head, Business Development

Last updated: 2024-12-31

Phibro Animal Health Corporation

Phibro Animal Health Corporation logo
Market Cap: Medium
Employees: High

animal health and mineral nutrition products

Phibro Animal Health Corporation develops, manufactures, and supplies a range of animal health and mineral nutrition products for livestock primarily in the United States, operating through segments like Animal Health, Mineral Nutrition, and Performance Products.

Tags: Animal Health, Antibacterials, Aquaculture, Biological Products, Cattle, Chemical Products, Livestock, Mineral Nutrition, Poultry, Swine

Symbol: PAHC

Recent Price: $20.97

Industry: Drug Manufacturers - Specialty & Generic

CEO: Mr. Jack Clifford Bendheim

Sector: Healthcare

Employees: 1940

Address: Glenpointe Centre East, Teaneck, NJ 07666-6712

Phone: 201 329 7300

Last updated: 2024-12-31

Merck & Co., Inc.

Merck & Co., Inc. logo
Market Cap: Highest
Employees: Highest

Pharmaceutical and Animal Health Products

Merck & Co., Inc. is a global healthcare company operating through Pharmaceutical and Animal Health segments, offering a wide range of human and veterinary products, including pharmaceuticals and vaccines.

Tags: Animal Health, Healthcare, Immunology, Oncology, Pharmaceutical, Vaccines, Veterinary

Symbol: MRK

Recent Price: $98.37

Industry: Drug Manufacturers - General

CEO: Mr. Robert M. Davis J.D.

Sector: Healthcare

Employees: 70000

Address: 2000 Galloping Hill Road, Kenilworth, NJ 07033

Phone: 908 740 4000

Last updated: 2024-12-31

Zoetis Inc.

Zoetis Inc. logo
Market Cap: Highest
Employees: Highest

Animal Health Medicines, Vaccines, and Diagnostic Products

Zoetis Inc. discovers, develops, and commercializes a wide range of animal health products including medicines, vaccines, and diagnostics, serving both livestock and companion animals globally.

Tags: Animal Health, Companion Animals, Diagnostics, Livestock, Pharmaceuticals, Vaccines, Veterinary Medicine

Symbol: ZTS

Recent Price: $162.24

Industry: Drug Manufacturers - Specialty & Generic

CEO: Ms. Kristin C. Peck

Sector: Healthcare

Employees: 14100

Address: 10 Sylvan Way, Parsippany, NJ 07054

Phone: 973 822 7000

Last updated: 2024-12-31

Adaptive Biotechnologies Corporation

Adaptive Biotechnologies Corporation logo
Market Cap: Medium
Employees: Medium

immunoSEQ

Adaptive Biotechnologies Corporation is a commercial-stage company that develops an immune medicine platform for diagnosing and treating various diseases, including COVID-19 and lymphoid cancers.

Tags: COVID-19, cancer, diagnostics, immune medicine, immunosequencing, translational research

Symbol: ADPT

Recent Price: $6.11

Industry: Biotechnology

CEO: Mr. Chad M. Robins M.B.A.

Sector: Healthcare

Employees: 709

Address: 1165 Eastlake Avenue East, Seattle, WA 98109

Phone: 206 659 0067

Last updated: 2024-12-31

Creative Medical Technology Holdings, Inc.

Creative Medical Technology Holdings, Inc. logo
Market Cap: Lowest
Employees: Lowest

Imm Celz

Creative Medical Technology Holdings, Inc. is a biotechnology company focusing on using adult stem cell treatments for immunology, urology, orthopedics, and neurology, offering solutions like Caver Stem, Fem Celz, Stem Spine, Imm Celz, and Ova Stem.

Tags: biotechnology, immunology, neurology, orthopedics, stem cell treatments, urology

Symbol: CELZ

Recent Price: $2.34

Industry: Biotechnology

CEO: Mr. Timothy Warbington

Sector: Healthcare

Employees: 4

Address: 211 East Osborn Road, Phoenix, AZ 85012

Phone: 480 399 2822

Last updated: 2024-12-31

Immix Biopharma, Inc.

Immix Biopharma, Inc. logo
Market Cap: Lowest
Employees: Lowest

IMX-110, IMX-111, IMX-120

Immix Biopharma, Inc. is a clinical-stage biopharmaceutical company developing tissue-specific therapeutics for oncology and inflammation, with clinical trials across the United States and Australia.

Tags: Biopharmaceuticals, Clinical Trials, Inflammation, Oncology, Tissue-Specific Therapeutics

Symbol: IMMX

Recent Price: $2.36

Industry: Biotechnology

CEO: Dr. Ilya Rachman M.B.A., M.D., MBA, Ph.D.

Sector: Healthcare

Employees: 14

Address: 11400 West Olympic Boulevard, Los Angeles, CA 90064

Phone: 310 651 8041

Last updated: 2024-12-31